Literature DB >> 33804365

ADHD: Reviewing the Causes and Evaluating Solutions.

Luis Núñez-Jaramillo1, Andrea Herrera-Solís2, Wendy Verónica Herrera-Morales1.   

Abstract

Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder in which patients present inattention, hyperactivity, and impulsivity. The etiology of this condition is diverse, including environmental factors and the presence of variants of some genes. However, a great diversity exists among patients regarding the presence of these ADHD-associated factors. Moreover, there are variations in the reported neurophysiological correlates of ADHD. ADHD is often treated pharmacologically, producing an improvement in symptomatology, albeit there are patients who are refractory to the main pharmacological treatments or present side effects to these drugs, highlighting the importance of developing other therapeutic options. Different non-pharmacological treatments are in this review addressed, finding diverse results regarding efficacy. Altogether, ADHD is associated with different etiologies, all of them producing changes in brain development, leading to the characteristic symptomatology of this condition. Given the heterogeneous etiology of ADHD, discussion is presented about the convenience of personalizing ADHD treatment, whether pharmacological or non-pharmacological, to reach an optimum effect in the majority of patients. Approaches to personalizing both pharmacological therapy and neurofeedback are presented.

Entities:  

Keywords:  ADHD; heterogeneous etiology; neurofeedback; pharmacological treatment; qEEG informed neurofeedback; treatment personalization

Year:  2021        PMID: 33804365      PMCID: PMC7999417          DOI: 10.3390/jpm11030166

Source DB:  PubMed          Journal:  J Pers Med        ISSN: 2075-4426


  211 in total

Review 1.  [Attention deficit hyperactivity disorder beyond adolescence. Time to think different?]

Authors:  María Teresa Acosta
Journal:  Medicina (B Aires)       Date:  2018       Impact factor: 0.653

2.  A Randomized Controlled Trial to Examine the Posttreatment Efficacy of Neurofeedback, Behavior Therapy, and Pharmacology on ADHD Measures.

Authors:  Inmaculada Moreno-García; Susana Meneres-Sancho; Carlos Camacho-Vara de Rey; Mateu Servera
Journal:  J Atten Disord       Date:  2017-02-01       Impact factor: 3.256

Review 3.  Molecular genetics of attention-deficit/hyperactivity disorder.

Authors:  Stephen V Faraone; Roy H Perlis; Alysa E Doyle; Jordan W Smoller; Jennifer J Goralnick; Meredith A Holmgren; Pamela Sklar
Journal:  Biol Psychiatry       Date:  2005-01-21       Impact factor: 13.382

4.  Effects of age and parental history of alcoholism on EEG findings in mission Indian children and adolescents.

Authors:  C L Ehlers; T L Wall; C Garcia-Andrade; E Phillips
Journal:  Alcohol Clin Exp Res       Date:  2001-05       Impact factor: 3.455

5.  QEEG-guided neurofeedback for recurrent migraine headaches.

Authors:  Jonathan E Walker
Journal:  Clin EEG Neurosci       Date:  2011-01       Impact factor: 1.843

6.  Serum brain-derived neurotrophic factor, glial-derived neurotrophic factor, nerve growth factor, and neurotrophin-3 levels in children with attention-deficit/hyperactivity disorder.

Authors:  Ayhan Bilgiç; Aysun Toker; Ümit Işık; İbrahim Kılınç
Journal:  Eur Child Adolesc Psychiatry       Date:  2016-08-25       Impact factor: 4.785

7.  Low blood lead levels associated with clinically diagnosed attention-deficit/hyperactivity disorder and mediated by weak cognitive control.

Authors:  Joel T Nigg; G Mark Knottnerus; Michelle M Martel; Molly Nikolas; Kevin Cavanagh; Wilfried Karmaus; Marsha D Rappley
Journal:  Biol Psychiatry       Date:  2007-09-14       Impact factor: 13.382

8.  Pronounced Hyperactivity, Cognitive Dysfunctions, and BDNF Dysregulation in Dopamine Transporter Knock-out Rats.

Authors:  Damiana Leo; Ilya Sukhanov; Francesca Zoratto; Placido Illiano; Lucia Caffino; Fabrizio Sanna; Giulia Messa; Marco Emanuele; Alessandro Esposito; Mariia Dorofeikova; Evgeny A Budygin; Liudmila Mus; Evgenia V Efimova; Marco Niello; Stefano Espinoza; Tatyana D Sotnikova; Marius C Hoener; Giovanni Laviola; Fabio Fumagalli; Walter Adriani; Raul R Gainetdinov
Journal:  J Neurosci       Date:  2018-01-18       Impact factor: 6.167

9.  Brain morphology in children with epilepsy and ADHD.

Authors:  Ricardo Saute; Kevin Dabbs; Jana E Jones; Daren C Jackson; Michael Seidenberg; Bruce P Hermann
Journal:  PLoS One       Date:  2014-04-23       Impact factor: 3.240

10.  Predicting Clinical Gains and Side Effects of Stimulant Medication in Pediatric Attention-Deficit/Hyperactivity Disorder by Combining Measures From qEEG and ERPs in a Cued GO/NOGO Task.

Authors:  Geir Ogrim; Juri D Kropotov
Journal:  Clin EEG Neurosci       Date:  2018-06-25       Impact factor: 1.843

View more
  3 in total

1.  New Hematological Parameters as Inflammatory Biomarkers: Systemic Immune Inflammation Index, Platerethritis, and Platelet Distribution Width in Patients with Adult Attention Deficit Hyperactivity Disorder.

Authors:  Hacer Akgül Ceyhun; Nilifer Gürbüzer
Journal:  Adv Neurodev Disord       Date:  2022-05-11

2.  Analysis of the therapeutic effect of Dimu Ningshen (TCM formula) on attention deficit hyperactivity disorder based on gut microbiota and serum metabolomics.

Authors:  Kairui Tang; Wenzhi Hao; Xiaowei Mo; Yueyue Chen; Xiaofang Guo; Liangliang He; Binghua Wang; Juxian Wang; Qingyu Ma; Lijuan Deng; Jiaxu Chen
Journal:  BMC Complement Med Ther       Date:  2022-01-25

3.  Clinical Efficacy Evaluation of Psychological Nursing Intervention Combined with Drugs Treatment of Children with ADHD under Artificial Intelligence.

Authors:  Ying Guo; Jinping Wang; Shuyan Yan; Shujie Sui
Journal:  J Healthc Eng       Date:  2022-03-29       Impact factor: 2.682

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.